Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BIODEL AG INC. maintains a focused presence in the Biotechnology & Pharmaceuticals technology area. The portfolio currently shows 1 pending office action, which is handled by a single distinct examiner. This concentration indicates a streamlined prosecution phase where all active matters are localized within 1 distinct art unit. Practitioners should note that this singular focus allows for a very direct engagement with the patent office.
The busiest examiner identified for this portfolio is LIU, SUE XU, who is responsible for the 1 pending office action currently on record. For a company operating in the complex Biotechnology & Pharmaceuticals sector, having such a consolidated examiner footprint means that the outcome of the entire pending portfolio depends on the specific requirements of this one individual. There are no other examiners or art units currently influencing the portfolio's trajectory.
The alignment of the single pending action with a single art unit suggests a highly specific technical focus for the company's current intellectual property efforts. Practitioners should focus on the specific examination style of LIU, SUE XU, as the administrative landscape is currently limited to this one point of contact. This simplicity in the examiner and art unit distribution can be leveraged to develop a highly specialized prosecution strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIU, SUE XU | 1 | 20.9% | +18.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18750625 | Compositions and Their Use for Pest Control and to Induce Plant Hormone and Gene Regulation for Improved Plant Production and Defense | LIU, SUE XU | 84d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18750625 | Compositions and Their Use for Pest Control and to Induce Plant Hormone and Gene Regulation for Improved Plant Production and Defense | LIU, SUE XU | 84d |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18750625 | Compositions and Their Use for Pest Control and to Induce Plant Hormone and Gene Regulation for Improved Plant Production and Defense | LIU, SUE XU | 1616 | §101 | Non-Final OA | 84d | Pending | Jun 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial